Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Product type
Topic
- Committees and advisory bodies (389)
- Scheduling (national classification system) (171)
- Safety monitoring and information (28)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
9 result(s) found, displaying 1 to 9
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 6 March 2025
-
Corporate reportsThe Australian Sunscreen Exposure Model performs sunscreen exposure calculations that reflect the unique conditions and practices in Australia.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 14 November 2024
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 14 March 2024
-
Corporate reportsWe commissioned the Health Design Lab to conduct market research to better understand the individual consumer, pharmacist and prescriber experiences of shortages and discontinuations.
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 3 March 2023
-
Corporate reportsThe TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
-
Corporate reportsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
Corporate reportsIn 2019, the TGA conducted 10 pharmacovigilance inspections of Australian medicine sponsors